NICE Approves Kite’s Yescarta as NHS Treatment for Aggressive Forms of Blood Cancer

NICE Approves Kite’s Yescarta as NHS Treatment for Aggressive Forms of Blood Cancer

1 February 2023
NICE Approves Kite’s Yescarta as NHS Treatment for Aggressive Forms of Blood Cancer
NICE has announced the approval of Kite’s CAR-T cell therapy Yescarta, for the treatment of patients with r/r DLBCL and PMBCL, who have already had two or more lines of systemic therapy.
Read More
Recent Stories
Eureka Therapeutics Awarded $10.6M CIRM Grant for T-Cell Therapy in Pediatric Liver Cancer
8 June 2023
Eureka Therapeutics Awarded $10.6M CIRM Grant for T-Cell Therapy in Pediatric Liver Cancer
Eureka Therapeutics has received a
Cell and Gene Therapy Catapult Open New Edinburgh, UK, Facilities
7 June 2023
Cell and Gene Therapy Catapult Open New Edinburgh, UK, Facilities
UK-based independent innovation and technology
BioCentriq® Unveils LEAP™ Advanced Therapy Platform, Enabling Rapid Patient Access for Early-Stage Biotech Companies
5 June 2023
BioCentriq® Unveils LEAP™ Advanced Therapy Platform, Enabling Rapid Patient Access for Early-Stage Biotech Companies
BioCentriq launched their new LEAP™
Nexcella Initiates NXC-201 Engineering Batches at its U.S. CAR-T Manufacturing Facility
2 June 2023
Nexcella Initiates NXC-201 Engineering Batches at its U.S. CAR-T Manufacturing Facility
Nexcella, a subsidiary of Immix
POPULAR NEWS ITEMS
Image
8 June 2023

Eureka Therapeutics Awarded $10.6M CIRM Grant for T-Cell Therapy in Pediatric Liver Cancer

Image
7 June 2023

Cell and Gene Therapy Catapult Open New Edinburgh, UK, Facilities

Image
5 June 2023

BioCentriq® Unveils LEAP™ Advanced Therapy Platform, Enabling Rapid Patient Access for Early-Stage Biotech Companies

denovoMATRIX Expands its Product Portfolio by Launching its First Stem Cell Product
2 June 2023
denovoMATRIX Expands its Product Portfolio by Launching its First Stem Cell Product
denovoMATRIX GmbH announced the expansion
FDA Accept BLA Application for Iovance Biotherapeutic’s Advanced Melanoma Cell Therapy
31 May 2023
FDA Accept BLA Application for Iovance Biotherapeutic’s Advanced Melanoma Cell Therapy
Biotechnology Company Iovance Biotherapeutics has
Load More News
RECOMENDED TOPICS
Cell Therapy
Clinical Trials
Industry Insights
Automation & Digitisation
Manufacturing
Skills, Talent & Development
CAR-X
Patient Access & Engagement
Strategy
Stem Cells
Regulatory & Standards
Finance & Investment
Gene Therapy
Collaborations, Mergers & Acquisitions
Viral/Non-Viral Vectors
Gene Editing
GMP
Partnering
Raw Materials
Scaling Up
NKx
Allogeneic
Characterisation
ATW
Events
Events – ATW
Reimbursement
Supply Chain
Cell-Based IO
Tissue Engineering
CMC
Logistics
Point of Care
Uncategorized
POPULAR NEWS ITEMS
Image

Excellos™ 360: Smart Starting Material Selection for Better Cells and Better Therapies 

Image

Eureka Therapeutics Awarded $10.6M CIRM Grant for T-Cell Therapy in Pediatric Liver Cancer

Image

Cell and Gene Therapy Catapult Open New Edinburgh, UK, Facilities